Liu D, Herranz-Blanco B, Mäkilä E, Arriaga LR, Mirza S, Weitz DA, Sandler N, Salonen J, Hirvonen J, Santos HA. 2013. Microfluidic Templated Mesoporous Silicon-Solid Lipid Microcomposites for Sustained Drug Delivery. ACS Appl. Mater. Interfaces (in Press)

Nyström M, Murtomaa M, Roine J, Sandler N, Salonen J. 2013. Processing of pharmaceutical materials by electrospraying under reduced pressure. Drug Dev Ind Pharm

Kolakovic, R., Viitala, T., Ihalainen, P. Genina, N., Peltonen, J., Sandler, N. Printing technologies in fabrication of drug delivery systems. Expert Opinion in Drug-Delivery 2013 (in press)

Yildir, E., Kolakovic, R., Genina, N., Trygg, J. Gericke, M., Hanski,L., Ehlers, H., Rantanen, J., Tenho, M., Vuorela, P., Fardim, P. Sandler, N. Tailored beads made of dissolved cellulose - Investigation of their drug release properties. Int. J. Pharm. 2013 (in Press)

Raijada, R., Genina, G., Fors, D., Wisaeus, E., Peltonen, J., Rantanen, J., Sandler, N. A Step towards Development of Printable Dosage Forms for Poorly Soluble Drugs. J.Pharm.Sci. 2013 (In press)

Genina, H. Fors, D., Palo, M., Peltonen, J., N. Sandler. Behavior of printable formulations of loperamide and caffeine on different substrates-Effect of print density in inkjet printing. Int. J. Pharm. 2013 (in Press)

N. Genina, E. M. Hoffmann, J. Breitkreutz, N. Sandler. Characterization of the inkjet-printed rasagiline mesylate on different substrates. Eur. J. Biopharm. 2013 (in Press)

Ana F.T. Silvaa, Anneleen Burggraeve, Quenten Denon, Paul Van der Meeren , Niklas Sandler, Tom Van Den Kerkhof, Mario Hellings, Chris Vervaet, Jean Paul Ramon, João Almeida Lopes, Thomas De Beer, Particle sizing measurements in pharmaceutical applications: comparison of in-process methods versus offline methods. Eur. J .Pharm. Biopharm. 2013 (in Press)

Hurler J.; Sørensen K.K.; Fallarero A.; Vuorela P.; Skalko-Basnet N. Liposomes-in-hydrogel delivery system with mupirocin: in vitro anti-biofilm studies and in vivo evaluation in mice burn model. Biomed Research International.(2013). In press, accepted November 11, 2013.

Sandler N.; Salmela I.; Fallarero A.; Rosling A.; Khajeheian M.; Kolakovic R.; Genina N.; Nyman J.; Vuorela P. Towards fabrication of 3D printed medical devices to prevent biofilm infections. International Journal of Pharmaceutics (2013). In press, accepted November 1, 2013.

Ausbacher D.; Fallarero A.; Kujala J.; Määttänen A.; Peltonen J.; Strøm M.B.; Vuorela P. Staphylococcus aureusbiofilm susceptibility to small and potent b 2,2- amino acid derivatives. Biofouling (2013). (http://dx.doi.org/10.1080/08927014.2013.847924).

Manner S.; Skogman M.; Goeres D.; Vuorela P.; Fallarero A. Systematic exploration of natural and synthetic flavonoids for inhibition of Staphylococcus aureus biofilms. International Journal of Molecular Sciences. (2013). 14(10):19434-51.

Fallarero A.; Skogman M.; Kujala J.; Rajaratnam M.; Moreira V.M.; Yli-Kauhaluoma J.; Vuorela P. (+)-Dehydroabietic acid, an abietane-type diterpene, inhibits Staphylococcus aureus biofilms in vitro. International Journal of Molecular Sciences (2013). 14(6): 12054-072.

Prinz M.; Parlar S.; Bayraktar G.; Alptüzün V.; Erciyas E.; Fallarero A.; Karlsson D.; Vuorela P.; Bureck M.; Förster C.; Turunc E.; Armagan G.; Yalcin A.; Krug M.; Sotriffer C.; Holzgrabe U. 1,4-Substituted 4-(1H)-pyridylene-hydrazone-type inhibitors for AChE, BuChE, and amyloid-β aggregation crossing the blood-brain-barrier European Journal of Pharmaceutical Sciences (2013). 49(4):603-13.

Narwal M.; Haikarainen T.; Fallarero A.; Vuorela P.; Lehtiö L. Screening and structural analysis of flavones inhibiting tankyrases Journal of Medicinal Chemistry. (2013). 56(9):3507-17.

Venkannagari H.; Fallarero A.; Feijs K.; Luscher B.; Lehtiö L. Activity-based assay for human mono-ADP-ribosyltransferases ARTD7/PARP15 and ARTD10/PARP10 aimed at screening and profiling inhibitors. European Journal of Pharmaceutical Sciences. (2013). 49(2):148-156.